Concepedia

D. Uprety

DU

Statistics

Publications

1

Citations

16

H-Index

1

Active since

2022

D. Uprety is an author specializing in lung cancer, radiation oncology, and cancer therapeutics.

Top concepts

Publications per year

2022–2022

1

Publications

1

975P Trastuzumab deruxtecan in patients (pts) with HER2-overexpressing (HER2-OE) metastatic non-small cell lung cancer (NSCLC): Results from the DESTINY-Lung01 trial

E.F. Smit, E. Felip, D. Uprety et al. · Annals of Oncology · 2022 · 16 citations

, , +6

1–1 of 1